DBVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DBV Technologies SA (DBVT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive trading signals, and while there is growth in revenue, the company is still operating at a significant net loss. Technical indicators are neutral, and there are no strong catalysts or recent influential trades to support a buy decision. It is better to hold off on investing in this stock until more favorable conditions or signals arise.
The MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 50.082, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 19.084), but there is no strong indication of a reversal or breakout.
The company is conducting clinical trials for its VIASKIN® Peanut Patch, which could lead to future growth if successful. Revenue increased significantly by 158.77% YoY in Q3 2025, showing potential for growth.
The company is still operating at a net loss of -33.16M in Q3 2025, and EPS dropped by -25.00% YoY. The stock has a 40% chance of declining in the next week and month based on historical patterns. No significant hedge fund, insider, or congress trading activity has been reported.
In Q3 2025, revenue increased to 2.77M (+158.77% YoY), but the company reported a net loss of -33.16M (+8.94% YoY improvement). EPS dropped to -0.24 (-25.00% YoY), and gross margin remained at 100%. While revenue growth is promising, the company remains unprofitable.
No recent analyst ratings or price target changes were provided. Wall Street sentiment is unclear, and there are no strong pros or cons views on the stock.
